Fallbericht
Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
Cutis · 2023
DOI: 10.12788/cutis.0874 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cutis, 2023. Verfasst von Lauren Schwartzberg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Schwartzberg is from the Department of Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania. Dr. Spizuoco is from True Dermatology PLL…. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Alopecia Areata.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Janus Kinase InhibitorsAlopecia AreataHumansPyrrolesAlopeciaHairPiperidinesPyrimidines
Substanzen
Janus Kinase InhibitorsPyrrolestofacitinibPiperidinesPyrimidines
Autor:innen und Institutionen
- Dr. Schwartzberg is from the Department of Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania. Dr. Spizuoco is from True Dermatology PLLC, New York, New York, and the Department of Dermatology, Mount Sinai…
Zitieren
APA
Schwartzberg, L., & Spizuoco, A. (2023). Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth. Cutis. https://doi.org/10.12788/cutis.0874
Vancouver
Schwartzberg L, Spizuoco A. Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth. Cutis. 2023. doi:10.12788/cutis.0874
BibTeX
@article{Schwartzberg2023,
author = {Schwartzberg, Lauren and Spizuoco, Amy},
title = {Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth},
journal = {Cutis},
year = {2023},
doi = {10.12788/cutis.0874}
}
EUVIMED